Unveiling the Etiology of Urological Tumors: A Systematic Review of Mendelian Randomization Applications in Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer
Urology Journal,
Vol. 21 (2024),
8 May 2024
,
Page 7970
https://doi.org/10.22037/uj.v21i.7970
Abstract
Background: Our study aims to address two pivotal questions: "What are the recent advancements in understanding the etiology of urological tumors through Mendelian Randomization?" and "How can Mendelian Randomization be more effectively applied in clinical settings to enhance patient health outcomes in the future?"
Methods: In our systematic review conducted in April 2023, we utilized databases like PubMed and Web of Science to explore the influence of Mendelian Randomization in urological oncological diseases. We focused on studies published from January 2018, employing keywords related to urological tumors and Mendelian Randomization, supplemented with MeSH terms and manual reference checks. Our inclusion criteria targeted original research studies, while we excluded reports and non-relevant articles. Data extraction followed a PICO-based approach, and bias risk was independently evaluated, with discrepancies resolved through discussion. This systematic approach adhered to PRISMA guidelines for accuracy and thoroughness in reporting.
Results: From the initial 457 publications, we narrowed down to 43 full-text articles after screening and quality assessments.A deeper understanding of Mendelian Randomization can help us explore risk factors with a clear causal relationship to urological tumors.This insight may pave the way for future research in early diagnosis, treatment, and management of associated diseases.
Conclusion: Our review underscores the value of MR in urogenital tumor research, highlighting its efficacy in establishing causality and its potential to clarify disease mechanisms. Despite challenges like large sample sizes and variant identification, MR offers new perspectives for understanding and managing these tumors, suggesting a trend towards more inclusive and diverse research approaches.
- Urologic system
- tumor
- Mendelian randomization
- review
How to Cite
References
Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127:3029-3030.
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019;5:1749-1768.
Papavasileiou G, Tsilingiris D, Spyrou N, et al. Obesity and main urologic cancers: Current systematic evidence, novel biological mechanisms, perspectives and challenges. Semin Cancer Biol. 2023;91:70-98.
Jensen BW, Meyle KD, Madsen K, Sørensen TIA, Baker JL. Early life body size in relation to risk of renal cell carcinoma in adulthood: a Danish observational cohort study. Eur J Epidemiol. 2020;35:251-258.
Fu R, Kim SJ. Inferring causality from observational studies: the role of instrumental variable analysis. Kidney Int. 2021;99:1303-1308.
Remein CD, Childs E, Pasco JC, et al. Content and outcomes of narrative medicine programmes: a systematic review of the literature through 2019. BMJ Open. 2020;10:e031568.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178-189.
Kurian AW, Abrahamse P, Furgal A, et al. Germline Genetic Testing After Cancer Diagnosis. JAMA. 2023;330:43-51.
Tuffaha H, Edmunds K, Fairbairn D, et al. Guidelines for genetic testing in prostate cancer: a scoping review. Prostate Cancer Prostatic Dis. Published online May 18, 2023.
Benn M, Nordestgaard BG. From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment. Cardiovascular Research. Published online February 19, 2018.
Sekula P, Del Greco M F, Pattaro C, Köttgen A. Mendelian Randomization as an Approach to Assess Causality Using Observational Data. JASN. 2016;27:3253-3265.
Katan MB. Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet. 1986;1:507-508.
Swerdlow DI, Kuchenbaecker KB, Shah S, et al. Selecting instruments for Mendelian randomization in the wake of genome-wide association studies. Int J Epidemiol. 2016;45:1600-1616.
Zheng J, Baird D, Borges MC, et al. Recent Developments in Mendelian Randomization Studies. Curr Epidemiol Rep. 2017;4:330-345. doi:10.1007/s40471-017-0128-6
Haycock PC, Burgess S, Wade KH, Bowden J, Relton C, Davey Smith G. Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Am J Clin Nutr. 2016;103:965-978.
Pierce SE, Booms A, Prahl J, van der Schans EJC, Tyson T, Coetzee GA. Post-GWAS knowledge gap: the how, where, and when. NPJ Parkinsons Dis. 2020;6:23.
Zhou W, Liu G, Hung RJ, et al. Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization. Int J Cancer. 2021;148:1077-1086.
Burgess S. Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int J Epidemiol. 2014;43:922-929.
Ge F, Huo Z, Liu Y, et al. Association between schizophrenia and prostate cancer risk: Results from a pool of cohort studies and Mendelian randomization analysis. Compr Psychiatry. 2022;115:152308.
de Leeuw C, Savage J, Bucur IG, Heskes T, Posthuma D. Understanding the assumptions underlying Mendelian randomization. Eur J Hum Genet. 2022;30:653-660.
Ma Z, Zhu C, Wang H, et al. Association between biological aging and lung cancer risk: Cohort study and Mendelian randomization analysis. iScience. 2023;26:106018.
Johnson KE, Siewert KM, Klarin D, et al. The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study. PLoS Med. 2020;17:e1003302.
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512-525.
Sanderson E. Multivariable Mendelian Randomization and Mediation. Cold Spring Harb Perspect Med. 2021;11:a038984.
Jin C, Li R, Deng T, et al. Association between dried fruit intake and pan-cancers incidence risk: A two-sample Mendelian randomization study. Front Nutr. 2022;9:899137.
Godos J, Tieri M, Ghelfi F, et al. Dairy foods and health: an umbrella review of observational studies. Int J Food Sci Nutr. 2020;71:138-151.
X S, D Y, L D, Y Q, X J, Y M. Genetically predicted levels of circulating cytokines and prostate cancer risk: A Mendelian randomization study. International journal of cancer. 2020;147.
Yu EYW, Dai Y, Wesselius A, et al. Coffee consumption and risk of bladder cancer: a pooled analysis of 501,604 participants from 12 cohort studies in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study. Eur J Epidemiol. 2020;35:523-535.
Wijarnpreecha K, Thongprayoon C, Thamcharoen N, Panjawatanan P, Cheungpasitporn W. Association between coffee consumption and risk of renal cell carcinoma: a meta-analysis. Intern Med J. 2017;47:1422-1432.
Nilsson LM, Johansson I, Lenner P, Lindahl B, Van Guelpen B. Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control. 2010;21:1533-1544.
Deng Y, Wu T, Luo G, Chen L. Exploring the casual association between coffee intake and bladder cancer risk using Mendelian Randomization. Frontiers in genetics. 2022;13:992599.
Wang M, Jian Z, Yuan C, Jin X, Li H, Wang K. Coffee Consumption and Prostate Cancer Risk: Results from National Health and Nutrition Examination Survey 1999-2010 and Mendelian Randomization Analyses. Nutrients. 2021;13:2317.
Li BH, Yan SY, Li XH, et al. Coffee and caffeine consumption and risk of renal cell carcinoma: A Mendelian randomization study. Front Nutr. 2022;9:898279.
Lu Y, Su H, Wang Y, Li H. Micronutrients and risks of three main urologic cancers: A mendelian randomization study. Front Nutr. 2023;10:1016243.
Xin J, Jiang X, Ben S, et al. Association between circulating vitamin E and ten common cancers: evidence from large-scale Mendelian randomization analysis and a longitudinal cohort study. BMC medicine. 2022;20:168.
Chen M, Xu Y, Xu J, Chancoco H, Gu J. Leukocyte Telomere Length and Bladder Cancer Risk: A Large Case-Control Study and Mendelian Randomization Analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2021;30:203-209.
Machiela MJ, Hofmann JN, Carreras-Torres R, et al. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma. Eur Urol. 2017;72:747-754.
Xu J, Chang WS, Tsai CW, et al. Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients. EBioMedicine. 2020;52:102616.
Wang M, Jian Z, Gao X, et al. Causal Associations Between Educational Attainment and 14 Urological and Reproductive Health Outcomes: A Mendelian Randomization Study. Frontiers in public health. 2021;9:742952.
Palumbo C, Pecoraro A, Knipper S, et al. Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology. Eur Urol Focus. 2021;7:644-652.
Johansson M, Carreras-Torres R, Scelo G, et al. The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study. PLoS Med. 2019;16:e1002724.
Chen M, Tsai CW, Chang WS, et al. High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study. Carcinogenesis. 2021;42:826-830.
Solarek W, Koper M, Lewicki S, Szczylik C, Czarnecka AM. Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators. J Cell Commun Signal. 2019;13:381-394.
Bo J, Yangyang Y, Jiayuan L, Siwen D, Yong C, Junbo Y. Evaluation of Bladder Clots Using a Nonsurgical Treatment. Urology. 2014;83:498-499.
Lees JS, Ho F, Parra-Soto S, et al. Kidney function and cancer risk: An analysis using creatinine and cystatin C in a cohort study. EClinicalMedicine. 2021;38:101030.
Lin Y, Yang Y, Fu T, et al. Impairment of kidney function and kidney cancer: A bidirectional Mendelian randomization study. Cancer Med. 2023;12:3610-3622.
Wan B, Ma N, Lu W. Mendelian randomization investigation identified the causal relationship between body fat indexes and the risk of bladder cancer. Peerj. 2023;11:e14739.
Xiong J, Yang L, Deng YQ, et al. The causal association between smoking, alcohol consumption and risk of bladder cancer: A univariable and multivariable Mendelian randomization study. International journal of cancer. 2022;151:2136-2143.
Gordetsky J, Spieker AJ, Pena MDCR, et al. Squamous Cell Carcinoma of the Bladder Is Not Associated With High-risk HPV. Urology. 2020;144:158-163.
Yan Y, Zhang H, Jiang C, et al. Human Papillomavirus Prevalence and Integration Status in Tissue Samples of Bladder Cancer in the Chinese Population. J Infect Dis. 2021;224:114-122.
Sun JX, Xu JZ, Liu CQ, et al. The association between human papillomavirus and bladder cancer: Evidence from meta-analysis and two-sample mendelian randomization. Journal of medical virology. 2023;95:e28208.
Teleka S, Häggström C, Nagel G, et al. Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women. Int J Cancer. 2018;143:3071-3082.
Seretis A, Cividini S, Markozannes G, et al. Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies. Sci Rep. 2019;9:8565.
Teleka S, Hindy G, Drake I, et al. Blood pressure and bladder cancer risk in men by use of survival analysis and in interaction with NAT2 genotype, and by Mendelian randomization analysis. PloS one. 2020;15:e0241711.
Du W, Wang T, Zhang W, Xiao Y, Wang X. Genetically supported causality between benign prostate hyperplasia and urinary bladder neoplasms: A mendelian randomization study. Frontiers in genetics. 2022;13:1016696.
Cumberbatch MGK, Jubber I, Black PC, et al. Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018. Eur Urol. 2018;74:784-795.
Gu D, Tang M, Wang Y, et al. The Causal Relationships Between Extrinsic Exposures and Risk of Prostate Cancer: A Phenome-Wide Mendelian Randomization Study. Front Oncol. 2022;12:829248.
Kazmi N, Haycock P, Tsilidis K, et al. Appraising causal relationships of dietary, nutritional and physical-activity exposures with overall and aggressive prostate cancer: two-sample Mendelian-randomization study based on 79 148 prostate-cancer cases and 61 106 controls. Int J Epidemiol. 2020;49:587-596.
Bl H, T R, S K, et al. Do sex hormones confound or mediate the effect of chronotype on breast and prostate cancer? A Mendelian randomization study. PLoS genetics. 2022;18.
BarChana M, Levav I, Lipshitz I, et al. Enhanced cancer risk among patients with bipolar disorder. J Affect Disord. 2008;108:43-48.
Osborn DPJ, Limburg H, Walters K, et al. Relative incidence of common cancers in people with severe mental illness. Cohort study in the United Kingdom THIN primary care database. Schizophr Res. 2013;143:44-49.
X C, J K, X D, et al. Depression and prostate cancer risk: A Mendelian randomization study. Cancer medicine. 2020;9.
Bandera Merchan B, Morcillo S, Martin-Nuñez G, Tinahones FJ, Macías-González M. The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences. J Steroid Biochem Mol Biol. 2017;167:203-218.
Capiod T, Barry Delongchamps N, Pigat N, Souberbielle JC, Goffin V. Do dietary calcium and vitamin D matter in men with prostate cancer? Nat Rev Urol. 2018;15:453-461.
Jiang X, Dimou NL, Al-Dabhani K, et al. Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study. Int J Epidemiol. 2019;48:1416-1424.
Lv L, Ye D, Chen J, et al. Circulating phosphorus concentration and risk of prostate cancer: a Mendelian randomization study. The American Journal of Clinical Nutrition. 2022;115:534-543.
Travis RC, Appleby PN, Martin RM, et al. A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk. Cancer Res. 2016;76:2288-2300.
El W, A PC, Gk F, et al. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis. International journal of epidemiology. 2023;52.
K SB, Pn A, Tj K, et al. The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition. Annals of oncology : official journal of the European Society for Medical Oncology. 2019;30.
- Abstract Viewed: 264 times
- Just Accepted-7970 Downloaded: 189 times